News Medical on MSN
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
There’s a mysterious energy quietly influencing your brain. Could it explain where your consciousness originates?
Dr Michael Chen, CEO and co‑founder of Nuclera, said: “Scientists are under pressure to progress increasingly complex membrane protein programs faster. By partnering with leadXpro, we can pair ...
Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common ...
Cambridge biotech Nuclera and Swiss company leadXpro have joined forces in a bid to fast-track membrane protein programmes.
A new approach to blue energy tackles one of the field’s most persistent problems: how to move ions quickly without sacrificing selectivity.
Brain cells are constantly swallowing material from the fluid that surrounds them—signaling molecules, nutrients, even pieces of their own surfaces—in a process known as endocytosis that is essential ...
The partnership combines RRG’s FDA-registered, CLIA-certified laboratory and industry-leading biologic products with ...
Producing clean hydrogen from water is often compared to storing renewable energy in chemical form, but improving the efficiency of that process remains a scientific challenge. Researchers at Tohoku ...
Storing hydrogen efficiently is still challenging. Researchers at Tohoku University have developed a new catalyst that coordinates the two key steps ...
Imagine a "smart fluid" whose internal structure can be rearranged just by changing temperature. In a new study published in Matter, researchers report a way to overcome a long-standing limitation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results